← Back to Search

Light Therapy

LED Light Therapy for Alopecia

N/A
Recruiting
Led By Amy McMichael, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women who are eighteen years of age or older with a biopsy-proven diagnosis of CCCA Stage II-III
Be older than 18 years old
Must not have
Males are excluded from this study since the prevalence of CCCA in males is so significantly low that it is difficult to find cases in a clinical setting
Subjects with other forms of hair loss that is not CCCA
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from month 4 to month 6 (end of study)
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether a light therapy cap can improve symptoms and hair growth in women with central centrifugal cicatricial alopecia, a form of scarring hair loss.

Who is the study for?
This trial is for women over 18 with a confirmed diagnosis of CCCA Stage II-III, who have been on a stable treatment plan for at least 3 months. It's not open to men or those with other types of hair loss, nor to individuals who've had prior light therapy for alopecia.
What is being tested?
The study tests the Revian Red All LED cap, which uses dual-band LED light therapy as a potential treatment for CCCA. The goal is to see if it can reduce scalp symptoms and hair loss while promoting hair regrowth in non-scarred areas.
What are the potential side effects?
Reportedly minimal side effects are associated with the Revian Red All LED cap, especially when compared to common treatments like topical minoxidil (itching and initial hair shedding) or finasteride (gynecomastia and libido loss).

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a woman over 18 with a confirmed diagnosis of CCCA Stage II-III.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am not a male, as males are not eligible for this study.
Select...
My hair loss is not due to CCCA.
Select...
I have used light therapy for hair loss before.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from month 4 to month 6 (end of study)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from month 4 to month 6 (end of study) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
hairline regrowth
hairline stabilization
Secondary study objectives
patient assessment of stabilization

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
Caps will be provided for each subjects will use the cap once daily for10-minute treatment regimen

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,401 Previous Clinical Trials
2,460,300 Total Patients Enrolled
Amy McMichael, MDPrincipal InvestigatorWake Forest University Health Sciences
6 Previous Clinical Trials
228 Total Patients Enrolled

Media Library

Revian Red All LED cap (Light Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT04764331 — N/A
Central Centrifugal Alopecia Research Study Groups: Intervention
Central Centrifugal Alopecia Clinical Trial 2023: Revian Red All LED cap Highlights & Side Effects. Trial Name: NCT04764331 — N/A
Revian Red All LED cap (Light Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04764331 — N/A
Central Centrifugal Alopecia Patient Testimony for trial: Trial Name: NCT04764331 — N/A
~0 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top